(Q34177217)

31 July 2017

1 reference

title

Chronic myeloid disorders: Classification and treatment overview (English)

1 reference

31 July 2017

1

Tefferi A

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

published in

Seminars in Hematology

1 reference

31 July 2017

volume

38

1 reference

31 July 2017

issue

1 Suppl 2

1 reference

31 July 2017

page(s)

1-4

1 reference

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Bone marrow transplantation for myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Mixed myelodysplastic and myeloproliferative syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

A clinical update in polycythemia vera and essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

No treatment for low-risk thrombocythaemia: results from a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Outcome analysis of 34 pregnancies in women with essential thrombocythemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Essential thrombocythemias. Clinical evolutionary and biological data

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Clinical course of essential thrombocythemia in 147 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Life expectancy of patients with chronic nonleukemic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990133-7

7 January 2021

10.1016/S0037-1963(01)90133-7

Identifiers

DOI

1 reference

31 July 2017

1 reference